Investor List:

Top Medical Devices Series B Investors in London (13)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Nicholas Bendt, Principal at Bain Capital
Nicholas Bendt
Bain Capital·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Inga Deakin, Principal at Molten Ventures
Inga Deakin
Molten Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Raleigh (NC), Investors in London
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Shamik Parekh, Investor at Octopus Ventures
Shamik Parekh
Sweet spot: $4.0M
Range: $1M - $20.0M
Investors in London, Investors in Israel, Investors in Europe, Investors in United Kingdom
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in AI (Series A), Investors in Israel (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Shahzad Malik, General Partner at Advent Life Sciences
Shahzad Malik
Advent Life Sciences·General Partner
Sweet spot: $1M
Range: $25K - $5.0M
Investors in London
Photo of Ronen Assia, Managing Partner at Team8
Ronen Assia
Team8·Managing Partner
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in London, Investors in Israel
Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in FinTech (Series B), Investors in Israel (Other Lists), Investors in FinTech (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in FinTech (Series A), Investors in FinTech (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in FinTech (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in London (Other Lists), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Andrew Ferguson, Partner at Baird Capital
Andrew Ferguson
Baird Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in SMB Software (Seed), Investors in Pharmaceuticals (Seed), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Data Services (Seed), Investors in IoT (Seed), Investors in Medical Devices (Series B), Investors in Data Services (Series A), Investors in IoT (Series B), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in SaaS (Series B), Investors in Consumer Health (Seed), Investors in Data Services (Seed), Investors in Health IT (Seed), Investors in IoT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in SaaS (Seed), Investors in SMB Software (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Data Services (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Medical Devices (Series A), Investors in SaaS (Series A), Investors in SMB Software (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Data Services (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in SaaS (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in SMB Software (Series B), Investors in London (Other Lists), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in SaaS (Seed)
Photo of Jason Foster, Venture Partner at Hambro Perks
Jason Foster
Hambro Perks·Venture Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in London
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Marketplaces (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in Pharmaceuticals (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Marketplaces (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Marketplaces (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Marketplaces (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Health IT (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Seed)
Photo of Genghis Lloyd-Harris, Partner at Abingworth
Genghis Lloyd-Harris
Abingworth·Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Get new data & insights delivered to your inbox